Philip Kremer (1984) trained as a neurologist at Amsterdam UMC, where he also did a PhD in bacterial genetics and bioinformatics. During this time, he worked at the Wellcome Trust Sanger Institute, Cambridge, UK for one year (2015). He joined CHDR in 2020, and currently holds the position of Research Director Neurology. He was also trained as a pharmacist at Utrecht University. He holds a staff position at the Department of Neurology at Leiden University Medical Center. In his role, he will focus on early phase drug development for neurological diseases, with a primary interest for neurodegenerative diseases.